|
|
| Bharat Immunologicals & Biologicals Corporation Limited |
|
Financials-Bharat Immunologicals & Biologicals Corporation Limited| Sector: Formulations | | BSE:524663 | NSE:NA | Bloomberg:BIMB@IN | Reuters:BIBC.BO | | Market Lot: 100 | Face Value: 10 | ISIN Demat: INE994B01014 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
251.99 |
284.84 |
-11.53 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
12.00 |
4.71 |
154.78 |
| Total Income |
263.99 |
289.55 |
-8.83 |
| Total Expenses |
-288.28 |
-321.58 |
-10.36 |
| OPBDIT |
552.27 |
611.13 |
-9.63 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-0.59 |
-321.58 |
-99.82 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
5.35 |
8.53 |
-37.28 |
| After Tax Profit |
-18.95 |
-23.50 |
-19.36 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-01(12) |
|
31-Mar-00(12) |
|
31-Mar-99(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
697.93 |
99.68 |
513.49 |
99.16 |
242.45 |
98.78 |
| Operating Income (OI) |
700.20 |
100.00 |
517.86 |
100.00 |
245.44 |
100.00 |
| OPBDIT |
182.55 |
26.07 |
195.32 |
37.72 |
53.27 |
21.70 |
| OPBDT |
61.62 |
8.80 |
54.92 |
10.61 |
-58.30 |
-23.75 |
| OPBT |
8.34 |
1.19 |
-6.06 |
-1.17 |
-120.45 |
-49.08 |
| Non-Operating Income |
4.09 |
0.58 |
6.50 |
1.26 |
0.00 |
0.00 |
| Extraordinary/Prior Period |
1.80 |
0.26 |
-0.02 |
-0.00 |
-0.62 |
-0.25 |
| Tax |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Profit after tax(PAT) |
14.23 |
2.03 |
0.42 |
0.08 |
-121.07 |
-49.33 |
| Cash Profit |
67.51 |
9.64 |
61.41 |
11.86 |
-58.92 |
-24.01 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-01 |
|
31-Mar-00 |
|
31-Mar-99 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
379.96 |
68.00 |
376.60 |
77.97 |
375.30 |
82.27 |
| Net Block |
183.29 |
32.80 |
210.50 |
43.58 |
242.12 |
53.08 |
| Capital WIP |
13.35 |
2.39 |
13.35 |
2.76 |
13.35 |
2.93 |
| Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Inventory |
180.48 |
32.30 |
96.13 |
19.90 |
31.11 |
6.82 |
| Receivables |
23.02 |
4.12 |
38.71 |
8.01 |
41.71 |
9.14 |
| Other Current Assets |
158.59 |
28.38 |
124.33 |
25.74 |
127.87 |
28.03 |
| Balance Sheet Total(BT) |
558.74 |
100.00 |
483.02 |
100.00 |
456.16 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
253.90 |
45.44 |
188.50 |
39.03 |
188.50 |
41.32 |
| Reserves |
-483.84 |
-86.60 |
-513.48 |
-106.31 |
-541.78 |
-118.77 |
| Total Debt |
499.79 |
89.45 |
556.40 |
115.19 |
234.07 |
51.31 |
| Creditors and Acceptances |
162.47 |
29.08 |
74.19 |
15.36 |
81.92 |
17.96 |
| Other current liab/prov. |
126.42 |
22.63 |
177.42 |
36.73 |
493.45 |
108.17 |
| Balance Sheet Total(BT) |
558.74 |
100.00 |
483.02 |
100.00 |
456.16 |
100.00 |
|
| As on |
31-Mar-01 |
31-Mar-00 |
31-Mar-99 |
| OPBIT/Prod.cap.empl.(%) |
50.40 |
61.60 |
6.70 |
| PBIT/Cap. Employed (%) |
52.70 |
64.58 |
7.17 |
| PAT/Networth (%) |
-6.19 |
-0.13 |
34.27 |
| Tax/PBT (%) |
0.00 |
0.00 |
0.00 |
| Total Debt/Networth (x) |
-2.17 |
-1.71 |
-0.66 |
| Long Term Debt/Networth (x) |
-1.97 |
-1.56 |
-0.53 |
| PBDIT/Finance Charges (x) |
1.56 |
1.44 |
0.47 |
| Current Ratio (x) |
1.25 |
1.03 |
0.35 |
| RM Inventory (days consumption) |
30.93 |
135.24 |
13.07 |
| FG inventory (days cost of sales) |
91.76 |
0.00 |
46.68 |
| Receivables (days gross sales) |
12.04 |
27.52 |
62.80 |
| Creditors (days cost of sales) |
114.56 |
83.95 |
155.60 |
| Op. curr. assets (days OI) |
189.00 |
183.00 |
298.00 |
|
|
Financials